Abstract:Data on the pharmacological management of acute agitation in schizophrenia are scarce. The aim of this study is to investigate the prescription practices in the treatment of agitation in Chinese patients with schizophrenia. We conducted a large, multicenter, observational study in 14 psychiatry hospitals in China. Newly hospitalized schizophrenia patients with the PANSS-EC total score ≥ 14 and a value ≥4 on at least one of its five items were included in the study. Their drug treatments of the first 2 weeks in hospital were recorded by the researchers. Eight hundred and 53 patients enrolled in and 847 (99.30%) completed the study. All participants were prescribed antipsychotics, 40 (4.72%) were prescribed benzodiazepine in conjunction with antipsychotics and 81 were treated with modified electric convulsive therapy (MECT). Four hundred and 12 (48.64%) patients were prescribed only one antipsychotic, in the order of olanzapine (120 patients, 29.13%), followed by risperidone (101 patients, 24.51%) and clozapine (41 patients, 9.95%). About 435 (51.36%) participants received antipsychotic polypharmacy, mostly haloperidol + risperidone (23.45%), haloperidol+ olanzapine (17.01%), olanzapine+ ziprasidone (5.30%), haloperidol + clozapine (4.37%) and haloperidol + quetiapine (3.90%). Binary logistic regression analysis suggests that a high BARS score (OR 2.091, 95%CI 1.140–3.124), severe agitation (OR 1.846, 95%CL 1.266–2.693), unemployment or retirement (OR 1.614, 95%CL 1.189–2.190) and aggressiveness on baseline (OR 1.469, 95%CL 1.032–2.091) were related to an increased antipsychotic polypharmacy odds. Male sex (OR 0.592, 95%CL 0.436–0.803) and schizophrenia in older persons (age ≥ 55 years, OR 0.466, 95%CL 0.240–0.902) were less likely to be associated with antipsychotic polypharmacy. The present study demonstrates that monotherapy and polypharmacy display equally common patterns of antipsychotic usage in managing agitation associated with schizophrenia in China. The extent and behavioral activities of agitation and several other factors were associated with polypharmacy.

Low Doses of Antipsychotic Drugs for Hospitalized Schizophrenia Patients in East Asia: 2004 Vs. 2001.

Prescribing Patterns of Low Doses of Antipsychotic Medications in Older Asian Patients with Schizophrenia, 2001–2009

Common use of high doses of antipsychotic medications in older Asian patients with schizophrenia (2001-2009).

Prescribing antipsychotic drugs for inpatients with schizophrenia in Asia: Comparison of REAP-2001 and REAP-2004 studies: Prescribing antipsychotics in REAP study

High Dose Antipsychotic Use in Schizophrenia: Findings of the REAP (research on East Asia Psychotropic Prescriptions) Study

Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.

Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).

Use of Anticholinergic Drugs in Patients with Schizophrenia in Asia from 2001 to 2009

Adjunctive Benzodiazepine Treatment Of Hospitalized Schizophrenia Patients In Asia From 2001 To 2008

Depot Antipsychotic Use in Schizophrenia: an East Asian Perspective

Adjunctive antidepressant prescriptions for hospitalized patients with schizophrenia in Asia (2001-2009).

Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009).

Common Use of Anticholinergic Medications in Older Patients with Schizophrenia: Findings of the Research on Asian Psychotropic Prescription Pattern (REAP) Study, 2001–2009

Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001-2009).

Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.

Adjunctive Mood Stabilizer Treatment for Hospitalized Schizophrenia Patients: Asia Psychotropic Prescription Study (2001-2008).

Adjunctive Antidepressant Use In Schizophrenia In China: A National Survey (2002-2012)

Use of Clozapine in Older Asian Patients with Schizophrenia Between 2001 and 2009

Haloperidol Concentrations Elevated in Chinese Patients.

Prescription Practices in the Treatment of Agitation in Newly Hospitalized Chinese Schizophrenia Patients: Data from a Non-Interventional Naturalistic Study

Factors That Influence the Prescription of Antipsychotics for Patients with Schizophrenia in China.